- Home
- PRLD vs LASE Comparison
PRLD vs LASE Comparison
Compare PRLD & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- LASE
- Stock Information
- Founded
- PRLD 2016
- LASE 2019
- Country
- PRLD United States
- LASE United States
- Employees
- PRLD N/A
- LASE N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- LASE Industrial Machinery/Components
- Sector
- PRLD Health Care
- LASE Industrials
- Exchange
- PRLD Nasdaq
- LASE Nasdaq
- Market Cap
- PRLD 44.0M
- LASE 42.1M
- IPO Year
- PRLD 2020
- LASE 2022
- Fundamental
- Price
- PRLD $1.01
- LASE $3.28
- Analyst Decision
- PRLD Strong Buy
- LASE
- Analyst Count
- PRLD 3
- LASE 0
- Target Price
- PRLD $4.00
- LASE N/A
- AVG Volume (30 Days)
- PRLD 133.9K
- LASE 7.0M
- Earning Date
- PRLD 08-14-2025
- LASE 08-18-2025
- Dividend Yield
- PRLD N/A
- LASE N/A
- EPS Growth
- PRLD N/A
- LASE N/A
- EPS
- PRLD N/A
- LASE N/A
- Revenue
- PRLD $7,000,000.00
- LASE $6,938,027.00
- Revenue This Year
- PRLD N/A
- LASE N/A
- Revenue Next Year
- PRLD N/A
- LASE N/A
- P/E Ratio
- PRLD N/A
- LASE N/A
- Revenue Growth
- PRLD N/A
- LASE 89.34
- 52 Week Low
- PRLD $0.61
- LASE $1.84
- 52 Week High
- PRLD $5.95
- LASE $19.80
- Technical
- Relative Strength Index (RSI)
- PRLD 52.78
- LASE 59.49
- Support Level
- PRLD $0.75
- LASE $2.45
- Resistance Level
- PRLD $0.96
- LASE $5.34
- Average True Range (ATR)
- PRLD 0.08
- LASE 0.33
- MACD
- PRLD 0.01
- LASE 0.09
- Stochastic Oscillator
- PRLD 67.87
- LASE 35.48
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About LASE Laser Photonics Corporation
Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.